Efficacy and tolerability of micronized purified flavonoid fractions (MPFF) for haemorrhoids: A systematic review and meta-analysis

Complementary Therapies in Medicine

Volumn 39, Issue , 2018, Pages 49-55

  Aziz, Zoriah ^a   Huin, Weng Kit ^a   Badrul Hisham, Muhammad Danish ^b   Tang, Wei Ling ^a   Yaacob, Saodah ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

Author keywords

Bleeding; Flavonoid; Meta analysis; Pain; Pruritus

Indexed keywords

FLAVONOID; MICRONIZED PURIFIED FLAVONOID FRACTION; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ADVERSE EVENT; BLEEDING; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HEMORRHOID; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PAIN; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM; SYSTEMATIC REVIEW;

FLAVONOIDS; HEMORRHAGE; HEMORRHOIDS; HUMANS; PRURITUS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85047800604     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2018.05.011     Document Type: Review

References (28)

1. Ganz, R.A., The evaluation and treatment of hemorrhoids: a guide for the gastroenterologist. Clin Gastroenterol Hepatol 11:6 (2003), 593–603.
2. Banov, L. Jr, Knoepp, L.F. Jr, Erdman, L.H., Alia, R.T., Management of hemorrhoidal disease. J S C Med Assoc 81:7 (1985), 398–401.
3. Madoff, R.D., Fleshman, J.W., American Gastroenterological Association technical review on the diagnosis and treatment of hemorrhoids. Gastroenterology 126:5 (2004), 1463–1473.
4. Rasouli, H., Farzaei, M.H., Khodarahmi, R., Polyphenols and their benefits: a review. Int J Food Prop 20:2 (2017), 1700–1741.
5. Misra, M.C., Parshad, R., Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids. Br J Surg 87:7 (2000), 868–872.
6. Ho, Y.H., Tan, M., Seow-Choen, F., Micronized purified flavonidic fraction compared favorably with rubber band ligation and fiber alone in the management of bleeding hemorrhoids. Dis Colon Rectum 43:1 (2000), 66–69.
7. Cospite, M., Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 45:6 Pt 2 (1994), 566–573.
8. Garg, A., Garg, S., Zaneveld, L.J., Singla, A.K., Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 15:8 (2001), 655–669.
9. Garner, R.C., Garner, J.V., Gregory, S., Whattam, M., Calam, A., Leong, D., Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J Pharm Sci 91:1 (2002), 32–40.
10. Lyseng-Williamson, K.A., Perry, C.M., Micronised purified flavonoid fraction. Drugs 63:1 (2003), 71–100.
11. Di Pierro, F., Spinelli, G., Monsù G., Clinical effectiveness of a highly standardized and bioavailable mixture of flavonoids and triterpenes in the management of acute hemorroidal crisis. Acta Biol Medica Atenei Parmensis 82:1 (2011), 43–48.
12. Dimitroulopoulos, D., Tsamakidis, K., Xinopoulos, D., Karaitianos, I., Fotopoulou, A., Paraskevas, E., Prospective: randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease. Clin Ther 27:6 (2005), 746–754.
13. Panpimanmas, S., Sithipongsri, S., Sukdanon, C., Manmee, C., Experimental comparative study of the efficacy and side effects of Cissus quadrangularis L. (Vitaceae) to Daflon (Servier) and placebo in the treatment of acute hemorrhoids. Med J Med Assoc Thail 93:12 (2010), 1360–1367.
14. Alonso-Coello, P., Zhou, Q., Martinez-Zapata, M.J., et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg 93:8 (2006), 909–920.
15. Perera, N., Liolitsa, D., Iype, S., et al. Phlebotonics for haemorrhoids. Cochrane Database Syst Rev, 15(August (8)), 2012, CD004322, 10.1002/14651858.CD004322.pub3.
16. Lefebvre, C., Eisinga, A., McDonald, S., Paul, N., Enhancing access to reports of randomized trials published worldwide-the contribution of EMBASE records to the CochraneCentral Register of Controlled Trials (CENTRAL) in the Cochrane Library. Emerg Themes Epidemiol, 2008, 5.
17. Higgins, J.P.T., Green, S., Chapter 9.5: heterogeneity. Deeks Higgins, J.J.J.P.T., Altman, D.G., (eds.) Cochrane Handbook for Systematic Reviews of Interventions (5.1.0 ed.), 2011, The Cochrane Collaboration Retrieved 12 September 2017 from www.cochrane-handbook.org.
18. Higgins, J.P.T., Green, S., Chapter 8: assessing risk of bias in included studies. Higgins, J.P.T., Altman, D.G., Sterne, J.A.C., (eds.) Cochrane Handbook for Systematic Reviews of Interventions (5.1.0 ed.), 2018, The Cochrane Collaboration Retrieved 12 September 2017 from www.cochrane-handbook.org.
19. Schünemann, H., Brożek, J., Guyatt, G., Oxman, A., The GRADE handbook. 2018 Retrieved 12 September 2017 from http://gdt.guidelinedevelopment.org/app/handbook/handbook.html.
20. Godeberge, P., Daflon 500 mg in the treatment of hemorrhoidal disease: a demonstrated efficacy in comparison with placebo. Angiology 45:6 Pt 2 (1994), 574–578.
21. Jiang, Z.M., Cao, J.D., The impact of micronized purified flavonoid fraction on the treatment of acute haemorrhoidal episodes. Curr Med Res Opin 22:6 (2006), 1141–1147.
22. Sarabia, M., León, S., Vivas, J., et al. Calcium dobesilate versus purified flavonoid fraction of diosmin in the treatment of hemorrhoidal crises: a randomized, controlled study with an initial double-blind, double-dummy period. Curr Ther Res 62:7 (2001), 524–529.
23. ®) in the treatment of hemorrhoids. Dis Rectum 35:11 (1992), 1085–1088.
24. Cospite, M., Cospite, V., Treatment of haemorrhoids with daflon 500 mg. Phlebol Suppl 2 (1992), 53–56.
25. Manach, C., Scalbert, A., Morand, C., Rémésy, C., Jiménez, L., Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:5 (2004), 727–747.
26. Karakaya, S., Bioavailability of phenolic compounds. Crit Rev Food Sci Nutr 44:6 (2004), 453–464.
27. Heleno, S.A., Martins, A., Queiroz, M.J.R.P., Ferreira, I.C.F.R., Bioactivity of phenolicacids: metabolites versus parent compounds: a review. Food Chem 173 (2015), 501–513.
28. Pildal, J., Hrobjartsson, A., Jørgensen, K.J., Hilden, J., Altman, D.G., Gøtzsche, P.C., Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 36:4 (2007), 847–857.